Developmental tumours, early differentiation and the transforming growth factor β superfamily

International Journal of Developmental Biology

Volumn 43, Issue 7, 1999, Pages 693-709

  Mummery, Christine L ^a   Van Den Eijnden Van Raaij, Adriana J M ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Embryonal carcinoma cells; Gene expression; Mouse embryo; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL DIFFERENTIATION; CELL ISOLATION; EMBRYONAL CARCINOMA; GENE EXPRESSION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; EMBRYO IMPLANTATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MULTIGENE FAMILY; NEOPLASMS, GERM CELL AND EMBRYONAL; PREGNANCY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA;

EID: 0033375411     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (162)

1. AKHURST, R.J., LEHNERT, S.A., FAISSNER, A. and DUFFIE, E. (1990). TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108: 645-656.
2. ALBANO, R.M. and SMITH, J.C. (1994). Follistatin expression in ES and F9 cells and in preimplantation mouse embryos. Int. J. Dev. Biol. 38: 543-547.
3. ALBANO, R.M., ARKELL, R., BEDDINGTON, R.S.P. and SM TH, J.C. (1994). Expression of inhibin subunits and follistatin during postimolantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain. Development 120: 803-813.
4. AMEERUN, R.F., DE WINTER, J.P., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., DEN HERTOG, J., DE LAAT, S.W. and TERTOOLEN, L.G.J. (1996). Activin and basic fibroblast growth factor regulate neurogenesis of murine emtryonal carcinoma cells. Cell Growth Differ. 7: 1679-1688.
5. ARMES, N.A. and SMITH, J.C. (1997). The ALK-2 and ALK-4 activin receptors transduce distinct mesoderm-inducing signals during early Xenopus development but do not co-operate to establish thresholds. Development 124: 3797-3804.
6. ASASHIMA, M., NAKANO, H., UCHIYAMA, H., SUGINO, H., NAKAMURA, T., ETO, Y., EJIMA, D., DAVIDS, M., PLESSOW, S., CICHOCKA, I. ard KINOSHITA, K. (1990). Mesoderm induction in early amphibian embryos by activin A (erythroid differentiation factor). Roux's Arch. Dev. Biol. 198: 330-335.
7. BATTEGAY, E.J., RAINES, E.W., SEIFERT, R.A., BOWEN-POPE, D.F. and ROSS, R. (1990). TGF-beta induces bimodal proliferation of connect ve tissue cells via complex control of an autocrine PDGF loop. Cell 63: 515-524.
8. BEHRENDTSEN, O., ALEXANDER, C.M. and WERB, Z. (1995). Cooperative interactions between extracellular matrix, integrins and parathyroid hormone-related peptide regulate parietal endoderm differentiation in mouse embryos. Development 121: 4137-4148.
9. BHUSHAN, A., LIN, H.Y., LODISH, H.F. and KITNER, C.R. (1994). The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm. Mol. Cell. Biol 144: 280-285.
10. BONYADI, M., RUSHOLME, S.A.B., COUSINS, F., SU, H.C., BIRON, C.A., FARRAL, M. and AKHURST, R.J. (1997). Mapping of a major genetic modifier of embryonic lethality in TGFβ 1 knockout mice. Nature Genet. 15: 207-215.
11. BÖTTINGER, E.P., JAKUBCZAK, J.L., ROBERTS, I.S., MUMY, M., HEMMATI, P., BAGNALL, K., MERLINO, G. and WAKEFIELD, L.M. (1997). Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16: 2621-2633.
12. BRUNO, E., HORRIGAN, S.K., VAN DEN BERG, D., ROZLER, E., FITTING, P.R., MOSS, S.T., WESTBROOK, C. and HOFFMAN, R. (1998). The SMAD 5 gene is involved in the intracellular signaling pathways that rneciate the inhibitory effects of transforming growth factor-β on human hematopoiesis. Blood 91: 1917-1923.
13. CARICASOLE, A.A.D., VAN SCHAIK, R.H.N., ZEINSTRA, L.M., WIERIKX, C.D.J., VAN GURP, R., VAN DEN POL, M., LOOIJENGA, L.H.J., OOSTERHUIS, J.W., PERA, M., WARD, A. DE BRUIJN, D., KRAMER, P., DE JONG, F.H. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1998). Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular tumours. Oncogens 16: 95-103.
14. CHAI, N., PATEL, Y., JACOBSON, K., MCMAHON, J., MCMAHON, A. and RAPPOLEE, D. A. (1998). FGF is an essential regulator of the fifth cell division in preimplantation mouse embryos. Dev. Biol. 198: 105-115.
15. CHANG, H., HUYLEBROECK, D., VERSCHUEREN, K., GUO, Q , MATZUK, M. and ZWIJSEN, A. (1999). Smad5 knockout mice die at mid-gestation from multiple embryonic and extraembryonic defects. Development 126: 1631-1642.
16. CONLON, F.L., LYONS, K., TAKAESU, N., BARTH, K.S., KISPERT, A., HERRMANN, B. and ROBERTSON, E. (1994). A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 120: 1919-1928.
17. CROTEAU, S., MENEZO, Y. and BENKHALIFA, M. (1995). Transforming growth factors a and β expression in fertilized and parthenogenetic pre-implantation mouse embryos: RNA detection with fluorescent insitu hybridisation. Dev. Growth Differ. 37: 433-440.
18. DAMJANOV, I., SOLTER, D., BELICZA, M. and SKREB, N. (1971). Teratomas obtained through extrauterine growth of seven-day-old mouse embryos. J. Natl. Cancer Inst. 46: 471-480.
19. DE LARCO, J.E. and TODARO, G.J. (1978). Growth factors from murine sarcoma virus transformed cells. Proc. Natl. Acad. Sci. USA 75: 4001-4005.
20. DE WINTER, J.P., DEVRIES, C.J.M., VAN ACHTERBERG, T.A.E., AMEERUN, R.F., FEIJEN, A., SUGINO, H., DEWAELE, P., HUYLEBROECK, D., VERSCHUEREN, K. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1996a). Truncated activin type II receptors inhibit activin bioactivity by the formation of heteromeric complexes with activin type I receptors. Exp. Cell Res. 224: 323-334.
21. DE WINTER, J.P., ROELEN, B.A.J., TEN DUKE, P., VAN DER BURG, B. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1997). D.P.C.4 (Smad4) mediates transforming growth factor β-1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumor cells. Oncogens 14: 1891-1899.
22. DE WINTER, J.P., TEN DUKE, P., DE VRIES, C.J.M., VAN ACHTERBERG, T.A.E., SUGINO, H., DE WAELE, P., HUYLEBROECK, D., VERSCHUEREN, K. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1996b). Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol. Cell. Endocrinol. 116: 105-114.
23. DEN HERTOG, J., PALS, E.G.M., PEPPELENBOSCH, M.P., TERTOOLEN, L.G.J., DE LAAT, S.W. and KRUIJER, W. (1993). Receptor protein tyrosine phophatase a activates pp60c-src and is involved in neuronal differentiation. EMBO J. 12: 3789-3798.
24. DICK, A., RISAU, W. and DREXLER, H. (1998). Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development. Dev. Dynamics 211: 293-305.
25. DICKSON, M.C., MARTIN, J.S., COUSINS, F.M., KULKARNI, A.B., KARLSSON, S. and AKHURST, R.J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factorβ1 knock out mice. Development 121: 1845-1854.
26. DICKSON, M.C., SLAGER, H.G., DUFFIE, E., MUMMERY, C.L. and AKHURST, R.J. (1993). RNA and protein localisations of TGFβ 2 in the early mouse embryo suggest an involvement in cardiac development. Development 117: 625-639.
27. DURSTON, A.J., TIMMERMANS, J.P.M., HAGE, W.J., HENDRIKS, H.F.J., DE VRIES, V.J., HEIDEVELD, M. and NIEUWKOOP, P.D. (1989). Retinoic acid causes an antero-posterior transformation in the developing central nervous system. Nature 340: 140-144.
28. ERLEBACHER, A., FILVAROFF, E.H., YE, J.Q. and DERYNCK, R. (1998). Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell 9: 1903-1918.
29. EVANS, M.J. and KAUFMAN, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
30. FANG, J.M., YIN, W.S., SMILEY, E., WANG, S.Q. and BONADIO, J. (1996). Molecular cloning of the mouse activin beta (e) subunit gene. Biochem. Biophys. Res. Commun 228: 669-674.
31. FEIJEN, A., GOUMANS, M.J. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1994). Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins. Development 120: 3621-3637.
32. FILVAROFF, E.H., EBNER, R. and DERYNCK, R. (1994). Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development 120: 1085-1095.
33. GEORGE, E.L., GEORGES-LABOUESSE, E.R., PATEL-KING, R.S., RAYBURN, H. and HYNES, R.O. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119: 1079-1091.
34. GEORGES-LABOUESSE, E.N., GEORGE, E.L., RAYBURN, H. and HYNES, R.O. (1996). Mesodermal development in mouse embryos mutant for fibronectin. Dev. Dynamics 207: 145-156.
35. GORSKA, A.E., JOSEPH, H., DERYNCK, R., MOSES, H.L. and SERRA, R. (1998). Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ. 9: 229-238.
36. GOUMANS, M-J. (1999). Functional analysis of TGFβ signalling in early mouse development. PhD Thesis, University of Utrecht, The Netherlands.
37. GOUMANS, M-J., WARD-VAN OOSTWAARD, D., WIANNY, F., SAVATIER, P., ZWIJSEN, A. and MUMMERY, C.L. (1998). Embryonic stem cells with aberrant TGF-p signalling exhibit impaired differentiation in vitro and in vivo. Differentiation 63: 101-113.
38. GOUMANS, M-J., ZWIJSEN, A., VAN ROOIJEN, M., HUYLEBROECK, D., ROELEN, B. and MUMMERY, C.L. (1999). Transforming growth factor p signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126: 3473-3483.
39. GU, Z., NOMURA, M., SIMPSON, B.B., LEI, H., FEIJEN, A., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., DONAHOE, P. and LI, E. (1998). The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev. 12: 844-857.
40. GU, Z., REYNOLDS, E.M., SONG, J., LEI, M., FEIJEN, A., YU, L., HE, W., MACLAUGHLIN, D.T., VAN DEN EIJNDEN-VAN RAAIJ, J., DONAHOE, P. and LI, E. (1999). The type I serine/threonine kinase receptor Ac+RIA (ALK2) is required for gastrulation of the mouse embryo. Development 126: 2551-2561.
41. HELDIN, C.H., MIYAZONO, K. and TEN DUKE, P. (1997). TGFp signalling from cell membrane to nucleus through Smad proteins. Nature 390: 465-471.
42. HIERCK, B.P., THORSTEINSDÓTTIR, S., NIESSEN, C.M., FREUND, E., IPEREN, L.V., FEYEN, A., HOGERVORST, F., POELMANN, R.E., MUMMERY, C.L. and SONNENBERG, A. (1993). Variants of the alpha 6 beta 1 laminin receptor in early murine development: distribution, molecular cloning and chromosomal localization of the mouse integrin alpha 6 subunit. Cell Adhesion Commun. 1: 33-53.
43. HOGAN, B.L.M., TAYLOR, A. and ADAMSON, E. (1981). Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature 291: 235-237.
44. HOTTEN, G. NEIHARDT, H., SCHNEIDER, C. and POHL, J. (1995). Cloning of a new member of the TGF-beta family: a putative new activin beta C chain. Biochem. Biophys. Res. Commun 206: 608-613.
45. JOHNSON, D.W., BERG, J.N., BALDWIN, M.A., GALLIONE, C.J., MARONDEL, I., YOON, S.-J., STENZEL, T.T., SPEER, M., PERICAK-VANCE, M.A., DIAMOND, A., GUTTMACHER, A.E., JACKSON, C.E., ATTISANO, L., KUCHERLAPATI, R., PORTEUS, M.E.M. and MARCHUK, D.A. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature Genet. 13: 189-195.
46. JONK, L.G.J., ITOH, S., HELDIN, C-H., TEN DUKE, P. and KRUIJER, W. (1998). Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor β, activin and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273: 21145-21152.
47. KAARTINEN, V., VONCKEN, J.W., SHULER, C., WARBURTON, D., BU, D., HEISTERKAMP, N. and GROFFEN, J. (1995). Abnormal lung development and cleft palate in mice lacking TGFp 3 indicates defects of epithelial-mesenchymal interaction. Nature Genet 11: 415-421.
48. KAY, E.P., LEE, M.S., SEONG, G.J. and LEE, Y.G. (1998). TGF-betas stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts. Curr. Eye Res. 17: 286-293.
49. KELLY, D. and RIZZINO, A. (1989). Inhibitory effects of transforming growth factor-β on laminin production and growth exhibited by endoderm-like cells derived from embryonal carcinoma cells. Differentiation 41: 39-41.
50. KLUG, M.G., SOONPAA, M.H., KOH, G.Y. and FIELD, L.J. (1996). Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98: 216-224.
51. KULKARNI, A.B., HUH, C.G., BECKER, D., GEISER, A., LYGHT, M., FLANDERS, K.C., ROBERTS, A.B., SPORN, M.B., WARD, J.M. and KARLSSON, S. (1993). Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
52. LABBÉ, E., SILVESTRI, C., HOODLESS, P.A., WRANA, J.L. and ATTISANO, L. (1998). Smad2 and Smad3 positively and negatively regulate TGF-beta dependent transcription through the forkhead DNA-binding protein fast2. Molecular Cell 2: 109-120.
53. LAGNA, G., HATA, A., HEMMATI-BRIVANLOU, A. and MASSAGUÉ, J. (1996). Partnership between DPC4 and SMAD proteins in TGFβ-signalling pathways. Nature 383: 832-836.
54. LAWITTS, J.A. and BIGGERS, J.D. (1991). Optimization of mouse embryo culture medium using simplex methods. J. Reprod. Fertil. 91: 543-546.
55. LEHNERT, S.A. and AKHURST, R.J. (1988). Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 104: 253-273.
56. LESUEUR, J.A. and GRAFF, J.M. (1999). Spemann organizer activity of Smad 10. Development 126: 137-146.
57. LETTERIO, J.J., GEISER, A.G., KULKARNI, A.B., ROCHE, N.S., SPORN, M.B and ROBERTS, A.B. (1994). Maternal rescue of transforming growth factor β1 null mice. Science 264: 1936-1938.
58. LI, M., PEVNY, L., LOVELL-BADGE, R. and SMITH. A. (1998). Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol. 8: 971-974.
59. LIM, J., BONGSO, A. and RATNAM, S. (1993). Mitogenic and cytogenetic evaluation of transforming growth factor-beta on murine preimplantation embryonic development in vitro. Mol. Reprod. Dev. 36: 482-487.
60. LIU, X.J., YUE, J.B., FREY, R.S., ZHU, G.C. and MULDER, K.M. (1998). Transforming growth factor beta signaling through SMAD 1 in human breast cancer cells. Cancer Res. 58: 4752-4757.
61. LÓPEZ-CASILLAS, F., WRANA, J.L. and MASSAGUÉ, J. (1993). Betaglycan presents ligand to the TGFp signaling receptor. Cell 67: 785-795.
62. LU, R.Z., MATSUYAMA, S., NISHIHARA, M. and TAKAHASHI, M. (1993). Developmental expression of activin/inhibin βA, βB, and α subunits, and activin receptor-IIB genes in preimplantation mouse embryos. Biol. Reprod. 49: 1163-1169.
63. MACIASSILVA, M., HOODLESS, P.A., TANG, S.J., BUCHWALD, M. and WRANA, J. L. (1998). Specific activation of SMAD 1 signaling pathways by the BMP7 type I receptor, ALK-2. J. Biol. Chem. 273: 25628-25636.
64. MAHMOOD, R., FLANDERS, K.C. and MORRISS-KAY, G.M. (1992). Interactions between retinoids and TGF betas in mouse morphogenesis. Development 115: 67-74.
65. MANOVA, K., DE LEON, V., ANGELES, M., KALANTRY, S. GIARRÉ, ATTISANO, L., WRANA, J. and BACHVAROVA, R.F. (1995). mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos. Mech. Dev. 49: 3-11.
66. MANOVA, K., PAYNTON, B.V. and BACHVAROVA, R.F. (1992). Expression of activins and TGFβ1 and β2 RNAs in early postimplantation mouse embryos and uterine decidua. Mech. Dev. 36: 141-152.
67. MARIANO, J.M., MONTUENGA, L.M., PRENTICE, M.A., CUTTITTA, F. and JAKOWLEW, S.B. (1998). Concurrent and distinct transcription and translation of TGFβ type I and type II receptors in rodent embryogenesis. Int. J. Dev. Biol. 42: 1125-1136.
68. MARTIN, G.R. (1980). Teratocarcinoma and mammalian embryogenesis. Science 209: 768-776.
69. MARTIN, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78: 7634-7638.
70. MATZUK, M.M., KUMAR, T.R. and BRADLEY. A. (1995a). Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374: 356-360.
71. MATZUK, M.M., KUMAR, T.R., VASSALLI, A., BICKENBACH, J.R., ROOP, D.R., JAENISCH, R. and BRADLEY, A. (1995b). Functional analysis of activins during mammalian development. Nature 374: 354-356.
72. MATZUK, M.M., LU, N., VOGEL, H., SELLHEYER, K., ROOP, D.R. and BRADLEY, A. (1995c). Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363.
73. MCBURNEY, M.W., JONES-VILLENEUVE, E.M.V., EDWARDS, M.K.S. and ANDERSON, P.J. (1982). Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299: 165-167.
74. MILLAN, F.A., DENHEZ, F., KONDAIAH, P. and AKHURST, R.J. (1991). Embryonic gene expression patterns of TGFβ 1, 2 and 3 suggest different developmental functions in vivo. Development 111: 131-143.
75. MISHINA, Y., SUZUKI, A., UENO, N. and BEHRINGER, R.R. (1995). Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9: 3027-3037.
76. MULDER, K.M. and MORRIS, S.L. (1992). Activation of p21ras by transforming growth factor beta in epithelial cells. J. Biol. Chem. 267: 5029-5031.
77. MUMMERY, C.L. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1990). Growth factors and their receptors in differentiation and early murine development. Cell Differ. Dev. 30: 1-18.
78. MUMMERY, C.L. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1993). Type β transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development. Int. J. Dev. Biol. 37: 169-182.
79. MUMMERY, C.L., FEIJEN, A., FREUND, E. and SHEN, S. (1990c). Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Differ. Dev. 30: 195-206.
80. MUMMERY, C.L., SLAGER, H.G., KRUIJER, W., FEIJEN, A., FREUND, E., KOORNNEEF, I. and VAN DEN EIJNDEN-VAN RAAIJ, A.L.M. (1990a). Expression of transforming growth factor β2 during the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 137: 161-170.
81. MUMMERY, C.L., VAN ACHTERBERG, T.A.E., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., VAN HAASTER, L., WILLEMSE, A., DE LAAT, S.W. and PIERSMA, A.M. (1991). Visceral endoderm-like cell lines induce differentiation of murine embryonal carcinoma cells. Differentiation 46: 51-60.
82. MUMMERY, C.L., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., FEIJEN, A., FREUND, E., HULSKOTTE, E., SCHOORLEMMER, J. and KRUIJER W. (1990b). Expression of growth factors during the differentiation of embryonic stem cells in monolayer. Dev. Biol. 142: 406-413.
83. MUMMERY, C.L., VAN ROOIJEN, M., BRACKE, M., VAN DEM EIJNDEN-VAN RAAIJ, A.J.M., VAN ZOELEN, E.J.J. and ALITALO, K. (1993). Fibroblast growth factor-mediated growth regulation and receptor expression ir embryonal carcinoma and embryonic stem cells and human germ cell tumours. Biochem. Biophys. Res. Commun 191: 188-195.
84. MUMMERY, C.L., VAN ROOIJEN, M.A., VAN DEN BRINK, S. and DE LAAT, S.W. (1987). Cell cycle analysis during retinoic acid induced d fferentiation of a human embryonal carcinoma-derived cell line. Cell Differ. 20: 153-160.
85. NAGY, A., GOZCA, E., MERENTES-DIAZ, E., PRIDEAUX, V.R., IVANYI, E., MARKKULA, M. and ROSSANT, J. (1990). Embryonic stem cells alone are able to support fetal development in the mouse. Development 110: 815-821.
86. NOMURA, M. and LI, E. (1998). Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393: 786-790.
87. ODA, S., NISHIMATSU, S., MUARAKAMI, K. and UENO, N. (1995). Molecular cloning and functional analysis of a new activin β subunit: a dorsal mesoderm-inducing activity in Xenopus. Biochem. Biophys. Res. Commun 210: 581-588.
88. OH, S.P. and LI, E. (1997). The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 11: 1812-1826.
89. OSHIMA, M., OSHIMA, H. and TAKETO, M.M. (1996). TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179: 297-302.
90. PADGETT, R.W., DAS, P. and KRISHNA, S. (1998). TGFp signaling, Smads, and tumor suppressors. BioEssays 20: 382-390.
91. PALIS, J., MCGRATH, K.E. and KINGSLEY, P.D. (1995). Initiation of haematopoiesis and vasculogenesis in murine yolk sac explants. Blood 86: 156-163.
92. PAPPAIOANNOU, V.E. (1981). Experimental chimaeras and the study of differentiation. In Mammalian Genetics and Cancer (ed. E.S. Russel) p76. Pub. AR Liss, New York.
93. PARIA, B.C. and DEY, S.K. (1990). Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. Proc. Natl. Acad. Sci. USA 87: 4756-4760.
94. PARIA, B.C., JONES, K.L., FLANDERS, K.C. and DEY, S.K. (1992). Localization and binding of transforming growth factorp isoforms in mouse preimplantation embryos and in delayed and activated blastocysts. Dev. Biol. 151: 91-104.
95. PAULUSMA, C.C., VAN DER KRUIJSSEN, C.M.M. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1994). Localization of activin subunits in early murine development determined by subunit-specific antibodies. J. Immunol. Methods 169: 143-152.
96. PERA, M.F., COOPER, S., MILLS, J. and PARRINGTON, J.M. (1989). Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation 42: 10-23.
97. PICCOLO, S., SASAI, Y., LU, B. and DEROBERTIS, E.M. (1996). Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86: 589-598.
98. POUPONNOT, C., JAYARAMAN, L. and MASSAGUÉ, J. (1998). Physical and functional interaction of Smads and p300/CBP. J. Biol. Chem. 273: 22865-22868.
99. PROETZEL, G., PAWLOWSKI, S.A., WILES, M.V., YIN, M., BOIVIN, G.P., HOWLES, P.N., DING, J., FERGUSON, M.W.J. and DOETSCHMAN. T. (1995). Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet. 11: 409-414.
100. RAPPOLEE, D.A., BRENNER, C.A., SCHULTZ, R., MARK, D. and WERB, Z. (1988). Developmental expression of PDGF, TGFα , and TGFβ genes in preimplantation mouse embryos. Science 241: 1823-1825.
101. RIZZINO, A. (1987). Appearance of high affinity receptors for type p transforming growth factor during differentiation of murine embryonal carcinoma cells. Cancer Res. 47: 4386-4390.
102. RIZZINO, A. (1988). Transforming growth factor-beta: multiple effects on cell differentiation and extracellular matrices. Dev. Biol. 130: 411-422.
103. ROBERTS, A.B., ANZANO, M.A., LAMB, L.C., SMITH, J.M. and SPORN, M.B. (1981). New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. USA 78: 5339-5343.
104. ROELEN, B.A.J., GOUMANS, M.J., VAN ROOIJEN, M.A. and MUMMERY, C.L. (1997a). Differential expression of BMP receptors in early mouse development. Int. J. Dev. Biol. 41: 541-549.
105. ROELEN, B.A.J., GOUMANS, M.J., ZWIJSEN, A. and MUMMERY, C.L. (1998). Identification of two distinct functions for TGFp in early mouse development. Differentiation 64: 19-31.
106. ROELEN, B.A.J., LIN, H.Y., KNEZEVIC, V., FREUND, E. and MUMMERY, C.L. (1994). Expression of TGFps and their receptors during gastrulation of the mouse embryo. Dev. Biol. 166: 716-728.
107. ROELEN. B.A.J., VAN ROOIJEN, M.A. and MUMMERY, C.L. (1997b). Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev. Dynamics 209: 418-430.
108. ROGERS, M.B., ROSEN, V., WOZNEY, J.M. and GUDAS, L.J. (1992). Bone morphogenetic proteins -2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells. Mol. Biol. Cell 3: 189-196.
109. RYDEN, M., IMAMURA, T., JORNVALL, H., BELLUARDO, N., NEVEU, I., TRUPP, M., OKADOME, T., TEN DUKE, P. and IBANEZ, C.F. (1996). A novel type 1 receptor serine-threonine kinase predominantly expressed in the adult central nervous system. J. Biol. Chem. 271: 30603-30609.
110. SANFORD, L.P., ORMSBY, I., GITTENBERG-DE GROOT, A.C., SARIOLA, H., FRIEDMAN, R., BOIVIN, G.P., CARDELL, E.L. and DOETSCHMAN, T. (1997). TGF beta 2 knockout mice have multiple developmental defects that are non-overlapping with other TGF beta knockout phenotypes. Development 124: 2659-2670.
111. SCHREWE, H., GENDRON-MAGUIRE, G., HARBISON, M. and GRIDLEY, T. (1994). Mice homozygous for a null mutation of activin βB are viable and fertile. Mech. Dev. 47: 43-51.
112. SERRA, R., JOHNSON, M., FILVAROFF, E.H., LABORDE, J., SHEEHAN, D.M., DERYNCK, R. and MOSES, H.L. (1997). Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell. Biol. 139: 541-552.
113. SHAMBLOTT, M.J., AXELMAN, J., WANG, S., BUGG, E.M., LITTLEFIELD, J.W., DONOVAN, P.J., BLUMENTHAL, P.D., HUGGINS, G.R. and GEARHART, J.D. (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95: 13726-13731.
114. SHOJI, H., NAKAMURA, T., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. and SUGINO, H. (1998). Identification of a novel type II activin receptor, type IIA-N, induced during the neural differentiation of murine P19 embryonal carcinoma cells. Biochem. Biophys. Res. Commun 246: 320-324.
115. SHULL, M.M., ORMSBY, I., KIER, A.B., PAWLOWSKI, S., DIEBOLD, R.J., YIN, M., ALLEN, R., SIDMAN, C., PROETZEL, G., CALVIN, D., ANNUNZIATA, N. and DOETSCHMAN, T. (1992). Targeted disruption of the mouse transforming growth factorp 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
116. SIRARD, C., DE LA POMPA, J.L., ELIA, A., ITIE, A., MIRTSOS, C., CHEUNG, A., HAHAN, S., WAKEHAM, A., SCHWARTZ, L., KERN, S.E., ROSSANT, J. and MAK, T.W. (1998). The tumor suppressor gene Smad4/DPC4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12: 107-119.
117. SLAGER, H.G., FREUND, E., BUITING, A.M.J., FEIJEN, A. and MUMMERY, C.L. (1993b). Secretion of transforming growth factor p isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation. J Cell Physiol. 156: 247-256.
118. SLAGER, H.G., LAWSON, K.A., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., DE LAAT, S.W. and MUMMERY, C.L (1991). Differential localization of TGFβ 2 in mouse preimplantation and early post-implantation development. Dev. Biol. 145: 205-218.
119. SLAGER, H.G., VAN INZEN, W., FREUND, E., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. and MUMMERY, C.L. (1993a). Transforming growth factor p in the early mouse embryo - implications for the regulation of muscle formation and implantation. Dev. Genet. 14: 212-224.
120. SMITH, J.C., PRICE, B.M.J., VAN NIMMEN, K. and HUYLEBROECK, D. (1990). Identification of a potent mesoderm-inducing factor as a homologue of activin A. Nature 345: 729-731.
121. SNOEK, G.T., KOSTER, C.H., DE LAAT, S.W., HEIDEVELD, M., DURSTON, A.J. and VAN ZOELEN, E.J.J. (1990). Effects of cell heterogeneity on production of polypeptide growth factors and mesoderm-inducing activity by Xenopus laevis XTC cells. Exp. Cell Res. 187: 203-210.
122. SOLTER, D. and DAMJANOV, I. (1982). Factors controlling the development of embryo-derived teratocarcinoma. In Teratocarcinoma and embryonic cell interactions (ed. T. Muramatsu et al.), p31. Academic Press, New York.
123. SONG, J., OH, S.P., SCHREWE, H., NOMURA, M., LEI, H., OKANO, M., GRIDLEY, T. and LI, E. (1999). The type II activin receptors are essential for egg cylinder growth gastrulation and rostral head development in mice. Dev. Biol. 213: 157-169.
124. SPINDLE, A. (1990). In vitro development of one-cell embryos from outbred mice: influence of culture medium composition. In vitro Cell. Dev. Biol. 25: 151-156.
125. STEVENS, L.C. (1968). The development of teratomas from intratesticular grafts of tubal mouse eggs. J. Embryol. Exp. Morphol. 20: 329-341.
126. STEVENS, L.C. and HUMMEL, K.P. (1957). A description of spontaneous congenital testicular teratomas in strain 129 mice. J. Natl. Cancer Inst. 18: 179.
127. STRICKLAND, S. and MAHDAVI, V. (1978). The induction of differentiation in terato-carcinoma cells by retinoic acid. Cell 15: 393-403.
128. THALLER, C. and EICHELE, G. (1987). Identification and spatial distribution of retinoids in the developing chick limb bud. Nature 327: 625-628.
129. THOMSON, J.A., ITSKOVITZ-ELDOR, J., SHAPIRO, S.S., WAKNITZ, M.A., SWIERGIEL, J.J., MARSHAL, V.S. and JONES, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
130. THORSTEINSDÓTTIR, S. (1992). Basement membrane and fibronectin matrix are distinct entities in the developing mouse blastocyst. Anat. Rec. 232: 141-149.
131. THORSTEINSDÓTTIR, S., ROELEN, B.A.J., GOUMANS, M-J., WARD-VAN OOSTWAARD, D., CASPAR, A. and MUMMERY, C.L. (1999). Expression of α6A integrin splice variant in developing mouse stem cell aggregates and correlation with cardiac muscle differentiation. Differentiation 64: 173-184.
132. TICKLE, C., LEE, J. and EICHELE, G. (1985). A quantitative analysis of all-transretinoic acid on the pattern of chick wing development. Dev. Biol. 109: 82-95.
133. TSUNG, H-C. and MUMMERY, C.L. (1990). Effects of feeder layer and BRL conditioned medium on mouse embryonic stem cells. Cell Research 1: 35-51.
134. VAN DE STOLPE, A., KARPERIEN, M., LOWIK, C.W., JUPPNER, H., SEGRE, G.V., ABOU-SAMRA, A.B., DE LAAT, S.W. and DEFIZE, L.H. (1993). Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J. Cell. Biol. 120: 235-243.
135. VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., FEIJEN, A., LAWSON, K.A. and MUMMERY, C.L. (1992). Differential expression of inhibin subunits and follistatin, but not of activin receptor type II, during early murine embryonic development. Dev. Biol. 154: 356-365.
136. VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., VAN ACHTERBERG, T.A.E., VAN DER KRUIJSSEN, C.M.M., PIERSMA, A.H., HUYLEBROECK, D., DE LAAT, S.W. and MUMMERY, C.L. (1991). Differentiation of aggregated murine P19 embryonal carcinoma cells is induced by a novel visceral endoderm-specific FGF-like factor and inhibited by activin A. Mech. Dev. 33: 157-166.
137. VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., VAN ZOELEN, E.J.J., VAN NIMMEN, K., KOSTER, C.H., SNOEK, G.T., DURSTON, A.J. and HUYLEBROECK, D. (1990). Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction. Nature 345: 732-734.
138. VAN DER KRUIJSSEN, C.M.M., FEIJEN, A., HUYLEBROECK, D. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1993). Modulation of activin expression by type β transforming growth factors. Exp. Cell Res. 207: 407-412.
139. VAN DER KRUIJSSEN, C.M.M., VAN ACHTERBERG, T.A.E., FEIJEN, A., HÉBERT, J.M., DEWAELE, P. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1995). Neuronal and mesodermal differentiation of P19 embryonal carcinoma cells is characterized by expression of specific marker genes and modulated by activin and fibroblast growth factors. Dev. Growth Differ. 37: 559-574.
140. VAN ZOELEN, E.J.J., WARD-VAN OOSTWAARD, T.M.J., NIEUWLAND, R., VAN DER BURG, B., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M., MUMMERY, C.L. and DE LAAT, S.W. (1989). Identification and characterization of polypeptide growth factors secreted by murine embryonal carcinoma cells. Dev. Biol. 133: 272-283.
141. VARLET, I., COLLIGNON, J. and ROBERTSON, E. (1997). Nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development 124: 1033-1044.
142. VASSALLI, A., MATZUK, M.M., GARDNER, H.A.R., LEE, K. and JAENISCH, R. (1994). Activin/inhibin βB subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8: 414-427.
143. VERHEIJEN, M.H.G. and DEFIZE, L.H.K. (1999). Signals governing extraembryonic endoderm formation in the mouse: involvement of the type 1 parathyroid hormone-related peptide (PTHrP) receptor, p21Ras and cell adhesion molecules. Int. J. Dev. Biol. 43: 711-721.
144. VERSCHUEREN, K, DEWULF, N., GOUMANS, M.J., LONNOY, O., FEIJEN, A., GRIMSBY, S., VAN DE SPIEGLE, K., TEN DUKE, P., MORÉN, A., VANSCHEEUWIJCK, P., HELDIN, C.H., MIYAZONO, K., MUMMERY, C., VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. and HUYLEBROECK, D. (1995). Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech. Dev. 52: 109-123.
145. WALDRIP, W.R., BIKOFF, EX., HOODLESS, P.A., WRANA, J.L. and ROBERTSON, E.J. (1998). Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92: 797-808
146. WANG, Y.Q., SIZELAND, A., WANG, X.F. and SASSOON, D. (1995). Restricted expression of type-II TGF beta receptor in murine embryonic development suggests a central role in tissue modeling and CNS patterning. Mech. Dev. 52: 275-289.
147. WANG, X.J., GREENHALGH, D.A., BICKENBACH, J.R., JIANG, A., BUNDMAN, D.S., KRIEG, T., DERYNCK, R. and ROOP, D.R. (1997). Expression of a dominant-negative type II TGFp receptor in the epidermis of transgenic mice blocks TGFβ-mediate growth inhiibition. Proc. Natl. Acad. Sci. USA 94: 2386-2391.
148. WEIMA, S.M., VAN ROOIJEN, M.A., FEIJEN, A., MUMMERY, C.L., VAN ZOELEN, E.J.J., DE LAAT, S.W. and VAN DEN EIJNDEN-VAN RAAIJ, A.J.M. (1989). Transforming growth factor p and its receptor are differentially regulated in human embryonal carcinoma cells. Differentiation 41: 245-253.
149. WEIMA, S.M., VAN ROOIJEN, M.A., MUMMERY, C.L., FEIJEN, A., DE LAAT, S.W. and VAN ZOELEN, E.J.J. (1990). Identification of the type-B receptor for platelet derived growth factor in human embryonal carcinoma cells. Exp. Cell Res. 186: 324-331.
150. WEIMA, S.M., VAN ROOIJEN, M., MUMMERY, C.L., FEIJEN, A., KRUIJER, W., DE LAAT, S.W. and VAN ZOELEN, E.J.J. (1988). Differentially regulated production of platelet-derived growth factor and of transforming growth factor p by a human teratocarcinoma cell line. Differentiation 38: 203-210.
151. WEINSTEIN, M., YANG, X., LI, C., XU, X., GOTAY, J. and DENG, C.X. (1998). Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc. Natl. Acad. Sci. USA 95: 9378-9383.
152. WHITMAN, M. (1998). Smads and early developmental signaling by the TGFp superfamily. Genes Dev. 12: 2445-2462.
153. WINNER, G., BLESSING, M., LABOSKY, P.A. and HOGAN, B.L.M. (1995). Bone
154. YAMASHITA, H., TEN DUKE, P., FRANZÉN, P., MIYAZONO, K. and HELDIN, C.H. (1994). Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor p. J. Biol. Chem. 269: 20172-20178.
155. YAMAUCHI, N., KIESSLING, A.A. and COOPER, G.M. (1994). The Ras/Raf signaling pathway is required for progression of mouse embryos through the two-cell stage. Mol. Cell. Biol. 14: 6655-6662.
156. YANG, J.T., RAYBURN, H. and HYNES, R.O. (1993). Embryonic mesodermal defects in α-5 deficient mice. Development 119: 1093-1105.
157. YANG, X., LI, C., XU, X. and DENG, C. (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad Sci. USA 95: 3667-3672.
158. ZHANG, H. and BRADLEY, A. (1996). Mice deficientfor BMP2are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.
159. ZHOU, S., ZAWEL, L., LENGAUER, C., KINZLER, K.W. and VOGELSTEIN, B. (1998). Characterization of human FAST-1, a TGFβ and activin signal transducer. Cell 2: 121-127.
160. ZHU, Y., RICHARDSON, J.A., PARADA, L.F. and GRAFF, J.M. (1998). Smad 3 mutant mice develop metastatic colorectal cancer. Cell 94: 703-714.
161. ZIMMERMAN, L.B., DEJESUSESCOBAR, J.M. and HARLAND, R.M. (1996). The Spemann organizer signal noggin binds and inactivates bone 3 morphogenetic protein 4. Cell 86: 599-606.
162. ZWIJSEN, A., GOUMANS, M-J., LAWSON, K.A., VAN ROOIJEN, M. and MUMMERY, C.L. (1999). Ectopic expression of the transforming growth factor p type II receptor disrupts mesoderm organisation during mouse gastrulation. Dev. Cyn. 214: 141-151.